In:
ELECTROPHORESIS, Wiley, Vol. 28, No. 13 ( 2007-07), p. 2252-2261
Abstract:
The biodistribution of colloidal carriers after their administration in vivo depends on the adsorption of some plasma proteins and apolipoproteins on their surface. Poly(methoxypolyethyleneglycol cyanoacrylate‐ co ‐hexadecylcyanoacrylate) (PEG‐PHDCA) nanoparticles have demonstrated their capacity to cross the blood–brain barrier (BBB) by a mechanism of endocytosis. In order to clarify this mechanism at the molecular level, proteins and especially apolipoproteins adsorbed at the surface of PEG‐PHDCA nanoparticles were analyzed by complementary methods such as CE and Protein Lab‐on‐chip® in comparison with 2‐D PAGE as a method of reference. Thus, the ability of those methodologies to identify and quantify human and rat plasma protein adsorption onto PEG‐PHDCA nanoparticles and conventional PHDCA nanoparticles was evaluated. The lower adsorption of proteins onto PEG‐PHDCA nanoparticles comparatively to PHDCA nanoparticles was evidenced by 2‐D PAGE and Protein Lab‐on‐chip® methods. CE allowed the quantification of adsorbed proteins without the requirement of a desorption procedure but failed, in this context, to analyze complex mixtures of proteins. The Protein Lab‐on‐chip® method appeared to be very useful to follow the kinetic of protein adsorption from serum onto nanoparticles; it was complementary to 2‐D PAGE which allowed the identification (with a relative quantification) of the adsorbed proteins. The overall results suggest the implication of the apolipoprotein E in the mechanism of passage of PEG‐PHDCA nanoparticles through the BBB.
Type of Medium:
Online Resource
ISSN:
0173-0835
,
1522-2683
DOI:
10.1002/elps.200600694
Language:
English
Publisher:
Wiley
Publication Date:
2007
detail.hit.zdb_id:
1475486-1
SSG:
12
Permalink